Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
549.81B
Market cap549.81B
Price-Earnings ratio
26.41
Price-Earnings ratio26.41
Dividend yield
2.29%
Dividend yield2.29%
Average volume
8.91M
Average volume8.91M
High today
$234.00
High today$234.00
Low today
$227.61
Low today$227.61
Open price
$232.10
Open price$232.10
Volume
18.99M
Volume18.99M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$149.04
52 Week low$149.04

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $228.60. The company's market cap stands at 549.81B, with a P/E ratio of 26.41 and a dividend yield of 2.29%.

On 2026-06-21, Johnson & Johnson(JNJ) stock traded between a low of $227.61 and a high of $234.00. Shares are currently priced at $228.60, which is +0.4% above the low and -2.3% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 18.99M, against a daily average of 8.91M.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

JNJ News

Simply Wall St 7h
Johnson & Johnson Stock Could Be 7.3% Undervalued Based On Its Pharma And MedTech Focus

Johnson & Johnson (JNJ) is back in focus after recent share price weakness, with the stock down 2% over the past month and about 3% over the past 3 months, prom...

Johnson & Johnson Stock Could Be 7.3% Undervalued Based On Its Pharma And MedTech Focus
24/7 Wall St. 12h
This Dividend Portfolio Pays More Than Social Security and a Part-Time Job Combined

This Dividend Portfolio Pays More Than Social Security and a Part-Time Job Combined By Drew Wood Published Jun 20, 4:57PM EDT Quick Read Replacing $42,000 in...

This Dividend Portfolio Pays More Than Social Security and a Part-Time Job Combined
The Motley Fool 17h
If I Had to Start Over With $1,000 in Stocks Today, Here's Exactly What I'd Buy

It's never too late to start investing. Whether the market is rising or falling, you'll always find opportunities to buy quality stocks that may deliver big res...

If I Had to Start Over With $1,000 in Stocks Today, Here's Exactly What I'd Buy

Analyst ratings

68%

of 25 ratings
Buy
68%
Hold
28%
Sell
4%

More JNJ News

BBC 1d
Crocodile attack on boy at Cambridgeshire zoo: What do we know? - BBC

...

Crocodile attack on boy at Cambridgeshire zoo: What do we know? - BBC
24/7 Wall St. 2d
The Retirement Portfolio That Forks Over a $10,000 Check Every Month

The Retirement Portfolio That Forks Over a $10,000 Check Every Month By Drew Wood Published Jun 19, 2:56PM EDT Quick Read A $10,000 monthly income requires $3...

The Retirement Portfolio That Forks Over a $10,000 Check Every Month
The Motley Fool 2d
Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm

Technology stocks make up nearly 40% of the value of the S&P 500 index (^GSPC +1.08%). It isn't that technology is unimportant, but that its weighting is more t...

Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm
Nasdaq 2d
Johnson & Johnson Could Be a Great Choice

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for i...

Johnson & Johnson Could Be a Great Choice
Nasdaq 2d
J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?

Johnson & Johnson’s JNJ stock has declined 3% in the past three months despite robust first-quarter 2026 results announced in January and fundamentally positive...

J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?
24/7 Wall St. 3d
The $1.5 Million Portfolio That Out-Earns the Median U.S. Household

The $1.5 Million Portfolio That Out-Earns the Median U.S. Household By Drew Wood Published Jun 18, 6:46AM EDT Quick Read A $1.5 million portfolio yields $52,5...

The $1.5 Million Portfolio That Out-Earns the Median U.S. Household
24/7 Wall St. 4d
The Dividend Growth Path That Turns $60,000 a Year Into $125,000

The Dividend Growth Path That Turns $60,000 a Year Into $125,000 By Drew Wood Published Jun 17, 4:42PM EDT Quick Read A starting yield of 3 to 4 percent growi...

The Dividend Growth Path That Turns $60,000 a Year Into $125,000

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.